Source comparison
Melanotan-2 vs PT-141 — Peptide Comparison | Real Peptides
Melanotan-2 and PT-141 (bremelanotide) both activate melanocortin receptors, but their selectivity profiles determine entirely different research applications. PT-141 was engineered specifically to eliminate the unwanted tanning and nausea effects of Melanotan
This comparison does not assign a generated winner or score.
- Melanotan-2 and PT-141 (bremelanotide) both activate melanocortin receptors, but their selectivity profiles determine entirely different research applications. PT-141 was engineered specifically to eliminate the unwanted tanning and nausea effects of Melanotan-2 while preserving sexual function pathways. That targeted modification means comparing melanotan-2 vs pt-141 isn't about choosing between two similar compounds. It's about understanding which melanocortin receptor subtype matters for your specific research question.
- We've worked with research teams using both peptides for over a decade. The confusion between these two compounds is so widespread that even experienced labs sometimes order the wrong one, expecting identical outcomes. Here's what genuinely separates them.
- What's the difference between Melanotan-2 and PT-141?
- Melanotan-2 is a non-selective melanocortin receptor agonist binding to MC1R, MC3R, MC4R, and MC5R, producing both tanning (via MC1R) and sexual response effects. PT-141 (bremelanotide) is a selective MC4R agonist derived from Melanotan-2 through structural modification, targeting sexual function pathways while avoiding MC1R-mediated pigmentation. The receptor selectivity difference eliminates tanning as a side effect in PT-141 research.
- The structural relationship matters because PT-141 wasn't discovered independently. It was intentionally engineered after researchers observed Melanotan-2's sexual side effects during tanning studies. That origin story explains why comparing melanotan-2 vs pt-141 requires understanding melanocortin receptor subtypes and what each controls. This article covers receptor binding profiles, pharmacokinetic differences, primary research applications for each compound, and side effect distinctions that determine which peptide fits specific experimental models.